Dr. Tad Gerlinger, M.D.
Joint Replacement Surgery (Adult Reconstructive Orthopaedic Surgery Physician)
1611 W Harrison St, Suite 400
Chicago, IL 60612
Who else practices at this address →
Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
Medicare and federal program status
Opted out of Medicare from July 1, 2025 through July 1, 2027. Medicare does not pay for this clinician’s services: patients with Medicare sign a private contract and pay the clinician directly. They can still order tests and refer Medicare patients to other providers.
Source: CMS Medicare Opt Out Affidavits (record last updated October 21, 2026). Opting out is a legal choice many clinicians make, often to run a cash or concierge practice.
At a glance
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 780
Licensed in Illinois since 2004, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Adult Reconstructive Orthopaedic Surgery Physician primary
IL license 036111139 (first issued 2004; active) -
Orthopaedic Surgery Physician
TX license M4089 (first issued 2006; canc non-renewal) · WV license 23111
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 780
- Services billed
- 7,645
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| X-ray of knee, 3 views | 434 | 310 |
| New patient office or other outpatient visit, 45-59 minutes | 399 | 399 |
| Established patient office or other outpatient visit, 10-19 minutes | 340 | 279 |
| X-ray of knee, 4 or more views | 296 | 237 |
| Injection, methylprednisolone acetate, 40 mg | 272 | 110 |
| X-ray of hip, 2-3 views | 254 | 194 |
| X-ray for bone length assessment | 208 | 143 |
| Aspiration and/or injection of fluid from large joint | 158 | 130 |
| Established patient office or other outpatient visit, 30-39 minutes | 109 | 106 |
| Replacement of knee joint, both sides of knee | 103 | 100 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Amoxicillin Other prescribers in Chicago, IL | 216 |
| Tramadol Hcl Other prescribers in Chicago, IL | 178 |
| Meloxicam Other prescribers in Chicago, IL | 110 |
| Oxycodone Hcl Other prescribers in Chicago, IL | 95 |
| Ondansetron Odt (ondansetron) Other prescribers in Chicago, IL | 76 |
| Gabapentin Other prescribers in Chicago, IL | 74 |
| Cefadroxil Other prescribers in Chicago, IL | 57 |
| Clindamycin Hcl Other prescribers in Chicago, IL | 47 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 9 payments worth $88,662 in total to this clinician.
| Smith+nephew, Inc. | $87,901 |
|---|---|
| Vertex Pharmaceuticals Incorporated | $511 |
| Kyocera Medical Technologies, Inc. | $200 |
| Solventum Corporation | $50.00 |
| Royalty or License | $82,051 |
|---|---|
| Consulting Fee | $6,348 |
| Food and Beverage | $263 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Smith+nephew, Inc. Aug 18, 2025 | Royalty or License JOURNEY II; JOURNEY II · Recon Knees | $22,211 |
| Smith+nephew, Inc. May 8, 2025 | Royalty or License JOURNEY II; JOURNEY II · Recon Knees | $21,744 |
| Smith+nephew, Inc. Feb 12, 2025 | Royalty or License JOURNEY II; JOURNEY II · Recon Knees | $19,175 |
| Smith+nephew, Inc. Nov 11, 2025 | Royalty or License JOURNEY II; JOURNEY II · Recon Knees | $18,921 |
| Smith+nephew, Inc. Mar 1, 2025 | Consulting Fee REAL INTELLIGENCE; JOURNEY II · Recon Robotics | $5,850 |
| Vertex Pharmaceuticals Incorporated May 21, 2025 | Consulting Fee | $498 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $5,087 in research payments for these studies, mostly to the institutions running them.
- A Prospective, Multicenter Post-Market Clinical Follow-Up Study to Evaluate the Safety and Effectiveness of the Journey II UNI Unicompartmental Knee System
Smith+nephew, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.